Green statoil asa sto rating reiterated goldman sachs group inc

Related Stories:

Living

Green

statoil asa sto rating reiterated goldman sachs group inc

going through breakup challenge

sheriff clarke slammed plagiarizing part master thesis

trick getting best deal online shopping

nisa investment advisors llc lowers stake neogen neog

Green Sun May 21 2017 15:34:43 GMT+0000 (UTC)
WHERE THE PARTY'S AT -- Goldman Sachs Group Inc reissued their sell rating on shares of Statoil ASA (NYSE:STO) in a research note released on Friday, May 5th. STO has been the topic of several other research reports. Scotiabank set a $17.00 price target on Statoil ASA and g
Citigroup Inc set a €110.00 ($120.88) price objective on Basf Se (ETR:BAS) in a research report report published on Friday, April 28th. The brokerage currently has a buy rating on the basic materials company’s stock. BAS has been
Nike Inc (NYSE:NKE) saw some unusual options trading on Thursday. Investors purchased 778 put options on the company. This represents an increase of approximately 136% compared to the average volume of 329 put options. Nike (NYSE:NKE) opened at 51.77
Guggenheim CurrencyShares Euro Trust (NYSE:FXE) was the recipient of some unusual options trading activity on Monday. Investors acquired 2,679 put options on the company. This is an increase of approximately 131% compared to the typical daily volume
Comstock Resources Inc (NYSE:CRK) – Investment analysts at KeyCorp cut their Q2 2017 earnings per share (EPS) estimates for shares of Comstock Resources in a report issued on Monday. KeyCorp analyst C. Stevens now expects that the oil and g
Traders sold shares of McDonald's Co. (NYSE:MCD) on strength during trading on Monday after an insider sold shares in the company. $73.92 million flowed into the stock on the tick-up and $122.78 million flowed out of the stock on the tick-dow
Press coverage about Cornerstone Progressive Return Fund (NYSE:CFP) has been trending negative this week, Alpha One Sentiment reports. Alpha One, a subsidiary of Accern, identifies negative and positive press coverage by analyzing more than 20 millio
Boston Partners raised its position in Civeo Co. (NYSE:CVEO) by 2.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,002,923 shares of the business services provide
Boston Partners lowered its stake in shares of Sun Bancorp, Inc. /NJ (NASDAQ:SNBC) by 1.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 128,100 share
Boston Partners reduced its stake in shares of La Quinta Holdings Inc (NYSE:LQ) by 24.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 239,185 shares of the company’s stock after selling
Boston Partners continued to hold its stake in shares of Dorian LPG Ltd (NYSE:LPG) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 317,981 shares of the shipping company’s stock at the end
Ctrip.Com International Ltd (NASDAQ:CTRP) had its price objective increased by Stifel Nicolaus from $58.00 to $63.00 in a research note released on Thursday, May 11th. They currently have a buy rating on the stock. Several other equities analysts hav
Domtar Corp (NYSE:UFS) (TSE:UFS) had its price target increased by Scotiabank from $38.50 to $40.50 in a research note released on Friday, April 28th. The firm currently has a sector perform rating on the basic materials company’s stock. Ot
JPMorgan Chase & Co. set a €175.00 ($192.31) target price on adidas AG (FRA:ADS) in a research report sent to investors on Friday, May 5th. The firm currently has a neutral rating on the stock. A number of other equities research a
Oppenheimer Holdings Inc. set a $132.00 price target on Zimmer Biomet Holdings Inc (NYSE:ZBH) in a research note released on Friday, April 28th. The firm currently has a buy rating on the medical equipment provider’s stock. Other analysts a
Oncomed Pharmaceuticals Inc (NASDAQ:OMED) – Research analysts at SunTrust Banks increased their Q2 2017 EPS estimates for Oncomed Pharmaceuticals in a note issued to investors on Monday. SunTrust Banks analyst P. Lawson now anticipates that
Arista Networks Inc (NYSE:ANET) had its price objective boosted by FBN Securities from $125.00 to $155.00 in a research note released on Monday, May 8th. The firm currently has an outperform rating on the technology company’s stock. Several